StonvexLoading…
StonvexStonvexStonvexCore line items from RCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.45B | $17.93B | $13.68B | $8.54B |
Operating Income | $1.16B | $4.91B | $3.98B | $2.27B |
Net Income | $941.00M | $4.27B | $3.51B | $1.94B |
EPS (Diluted) | $3.48 | $15.61 | $12.83 | $7.10 |
Total Assets | $41.99B | $41.62B | $40.11B | $38.54B |
Total Liabilities | $31.96B | $31.37B | $29.82B | $29.18B |
Cash & Equivalents | $512.00M | $825.00M | $432.00M | $735.00M |
Free Cash Flow OCF − CapEx | $1.33B | $1.24B | $1.12B | $2.11B |
Shares Outstanding | 271.00M | 274.00M | 275.00M | 275.00M |